The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
|Articles|May 15, 2020
Latest in People and Business
The latest happenings in the industry, all in one place.
Advertisement
People News
Cytel Inc. has announced the hire of Thomas Bregenzer as the new Global Head of Biostatistics.
Datacubed Health has named Brett Kleger as its new CEO.
AiCure appoints former Medidata Founder, Dr. Ed Ikeguchi, as CEO.
Illingworth Research Group has announced that John Illingworth, the founder, owner and current Chief Executive Officer (CEO), is moving into the position of Chairman. The CEO position will be taken by the current Chief Operating Officer (COO), Helen Springford. Gerard Barron, previously Director of Clinical Operations, has been promoted to Vice President, Operations. Lastly, Director of Research Nursing, Juliet Hulse has been promoted to Senior Director Global Research Nursing Strategy and Patient Advocacy.
Business News
The Regulatory Affairs Professionals Society (RAPS) added another European chapter as it announced the launch of the RAPS Germany Chapter.
Datacubed Health announced the launch of Linkt Virtual Visit, the latest module to its patient engagement/eCOA solution.
Parexel announced the deployment of nearly 30 employee volunteers to help administer and oversee COVID-19 testing across the UK in partnership with the Association of Clinical Research Organizations.
Recognition
CluePoints announced that its recently launched complimentary COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies that are directly affected by COVID-19.
Advertisement
Related to this article
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
AstraZeneca and Oracle Outline AI Collaboration for Clinical Trial Recruitment and Safety Monitoring
What sponsors and sites should know about the AstraZeneca-Oracle AI collaboration on trial recruitment, safety monitoring and data governance.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where AI Governance in Clinical Development Falls Short
4
Syneos Health, Optum Partner on Adaptive Clinical Development Model
5